About
Venture Partner focused on cardiometabolic disease, obesity and diabetes, with drug development and commercialization expertise. Joined Versant in July 2024 after nearly a decade at Novo Nordisk (where he founded its Seattle Obesity Research unit) and 20 years at Oregon Health Science University.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures